← Back to Search

COVID-19 Vaccine Uptake App + General Health App for COVID-19 (MoVeUP Trial)

N/A
Waitlist Available
Led By Russell J. McCulloh, MD
Research Sponsored by University of Arkansas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 24
Awards & highlights

Summary

This trial will help determine if a mobile app can increase the number of parents who vaccinate their children against COVID-19.

Eligible Conditions
  • Coronavirus Vaccines
  • Telemedicine
  • Vaccine Hesitancy
  • Acute Lymphoblastic Leukemia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 24
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 24 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of children who complete COVID-19 vaccination, as verified in state, clinic, or participant-held records
Secondary outcome measures
Change in enrolled parent/caregiver domain scores from baseline to immediately post-intervention on the modified WHO SAGE Vaccine Hesitancy Scale adapted for the COVID-19 Vaccine
Proportion of children who receive ≥1 dose of the COVID-19 vaccination series, as verified in state, clinic, or participant-held records

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Vaccine Uptake AppExperimental Treatment1 Intervention
24-week (8 weeks with weekly push notifications; 2 monthly push notifications for 2 months [1 notification per month]; 8 weeks without) exposure to a mobile phone application (app) designed to improve parental knowledge, attitudes, and self-efficacy regarding pediatric COVID-19 vaccination. The app will address logistical and motivational barriers to pediatric COVID-19 vaccination. Participants will also receive eight weekly nudges and 1 monthly nudge for 2 months (cues to action) regarding vaccinating their child that will be sent to participants via push notifications to their mobile devices. Through branching logic, users will access content tailored to their COVID-19 vaccine knowledge and confidence gaps, locality, degree of rural-urban primary residence, primary language (English/Spanish), race/ethnicity, and child's age.
Group II: General Health AppActive Control1 Intervention
24-week (8 with weekly push notifications; 2 monthly push notifications for 2 months [1 notification per month]; 8 weeks without) exposure to a mobile phone app designed to provide information on general pediatric health and infection prevention and mitigation strategies based on recommendations from the American Academy of Pediatrics (AAP) and the Centers for Disease Control and Prevention (CDC). Eight weekly nudges and 1 monthly nudge for 2 months regarding these topics will be sent to participants via push notifications to their mobile devices.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
COVID-19 Vaccine Uptake App
2022
N/A
~730

Find a Location

Who is running the clinical trial?

University of ArkansasLead Sponsor
488 Previous Clinical Trials
149,742 Total Patients Enrolled
IDeA States Pediatric Clinical Trials NetworkLead Sponsor
5 Previous Clinical Trials
464 Total Patients Enrolled
University of MontanaOTHER
24 Previous Clinical Trials
2,847 Total Patients Enrolled

Media Library

COVID-19 Vaccine Uptake App Clinical Trial Eligibility Overview. Trial Name: NCT05386355 — N/A
Coronavirus Vaccines Research Study Groups: Vaccine Uptake App, General Health App
Coronavirus Vaccines Clinical Trial 2023: COVID-19 Vaccine Uptake App Highlights & Side Effects. Trial Name: NCT05386355 — N/A
COVID-19 Vaccine Uptake App 2023 Treatment Timeline for Medical Study. Trial Name: NCT05386355 — N/A
~242 spots leftby Jul 2025